{"date":"2026-11-20","count":17,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6696-2026-11-20-2125-grl24n","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-11-20","time":"21:25:49","subject":"代重要子公司Belite Bio,Inc公告LBS-008用於治療斯特格病變之新藥查驗登記申請(NDA)經美國食品藥物管理局(FDA)通知延長審查期間3個月及預計溝通藥品仿單要求(labeling requests)時間","clause":"第44款","fact_date":"2026-11-20","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-11-20 21:25，「代重要子公司Belite Bio,Inc公告LBS-008用於治療斯特格病變之新藥查驗登記申請(NDA)經美國食品藥物管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-11-20-2023-1hkj5dk","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-11-20","time":"20:23:37","subject":"係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解","clause":"第51款","fact_date":"2026-11-20","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-11-20 20:23，「係因本公司有價證券於集中交易市場達公布注意交易資訊標準，故公布相關財務業務等重大訊息，以利投資人區別瞭解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4771-2026-11-20-1927-5j9o7v","company_id":"4771","company":"望隼","market":"上市","industry":"生技醫療","date":"2026-11-20","time":"19:27:29","subject":"公告本公司受邀參加凱基證券舉辦之法人說明會","clause":"第12款","fact_date":"2026-11-23","cite_as":"公開資訊觀測站重大訊息：望隼（4771），2026-11-20 19:27，「公告本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-11-20-1900-nyhm15","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-11-20","time":"19:00:12","subject":"代公告子公司共信寵物生醫股份有限公司申請寵物抗癌用藥思沛康注射液(GWA103)檢驗登記案，收到農業部通知取領許可證","clause":"第10款","fact_date":"2026-11-20","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-11-20 19:00，「代公告子公司共信寵物生醫股份有限公司申請寵物抗癌用藥思沛康注射液(GWA103)檢驗登記案，收到農業部通知取領許可證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1271-2026-11-20-1720-83cnsy","company_id":"1271","company":"晨暉生技","market":"興櫃","industry":"生技醫療","date":"2026-11-20","time":"17:20:35","subject":"公告本公司115年第二次股東臨時會重要決議事項","clause":"第15款","fact_date":"2026-11-20","cite_as":"公開資訊觀測站重大訊息：晨暉生技（1271），2026-11-20 17:20，「公告本公司115年第二次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2026-11-20-1705-1lws1g4","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2026-11-20","time":"17:05:15","subject":"更正本公司115年第三季合併財務報告附註附表五、台聯電訊股份有限公司及子公司合併財務報表附註(續)","clause":"第53款","fact_date":"2026-11-20","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2026-11-20 17:05，「更正本公司115年第三季合併財務報告附註附表五、台聯電訊股份有限公司及子公司合併財務報表附註(續)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2026-11-20-1651-ize6bg","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2026-11-20","time":"16:51:44","subject":"公告本公司一年內累積處分同一有價證券達實收資本額百分之二十（更正監察人承認或審計委員會同意日期）","clause":"第17款","fact_date":"2026-11-20","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2026-11-20 16:51，「公告本公司一年內累積處分同一有價證券達實收資本額百分之二十（更正監察人承認或審計委員會同意日期）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7725-2026-11-20-1643-1jm8xii","company_id":"7725","company":"列特博","market":"興櫃","industry":"生技醫療","date":"2026-11-20","time":"16:43:10","subject":"公告本公司一年內累積處分同一有價證券達實收資本額百分之二十","clause":"第17款","fact_date":"2026-11-20","cite_as":"公開資訊觀測站重大訊息：列特博（7725），2026-11-20 16:43，「公告本公司一年內累積處分同一有價證券達實收資本額百分之二十」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-11-20-1612-142ih3h","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-11-20","time":"16:12:44","subject":"公告本公司證券簡稱由「沛爾生醫*-創」變更為「沛爾*-創」","clause":"第51款","fact_date":"2026-11-17","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-11-20 16:12，「公告本公司證券簡稱由「沛爾生醫*-創」變更為「沛爾*-創」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2026-11-20-1530-1sb5bo","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-11-20","time":"15:30:52","subject":"公告本公司董事會決議召開116年第一次股東臨時會相關事宜","clause":"第32款","fact_date":"2026-11-20","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-11-20 15:30，「公告本公司董事會決議召開116年第一次股東臨時會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6617-2026-11-20-1529-1riyvmo","company_id":"6617","company":"共信-KY","market":"上櫃","industry":"生技醫療","date":"2026-11-20","time":"15:29:06","subject":"代子公司共信醫藥科技股份有限公司公告向日本專利局提出之專利申請案號數：特願2023-190260，已獲核准通知","clause":"第53款","fact_date":"2026-11-20","cite_as":"公開資訊觀測站重大訊息：共信-KY（6617），2026-11-20 15:29，「代子公司共信醫藥科技股份有限公司公告向日本專利局提出之專利申請案號數：特願2023-190260，已獲核准通知」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4736-2026-11-20-1513-1p5h1m5","company_id":"4736","company":"泰博","market":"上市","industry":"生技醫療","date":"2026-11-20","time":"15:13:14","subject":"公告本公司召開法人說明會相關資訊","clause":"第12款","fact_date":"2026-11-23","cite_as":"公開資訊觀測站重大訊息：泰博（4736），2026-11-20 15:13，「公告本公司召開法人說明會相關資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4126-2026-11-20-1500-oihymi","company_id":"4126","company":"太醫","market":"上櫃","industry":"生技醫療","date":"2026-11-20","time":"15:00:46","subject":"本公司受邀參加櫃買中心舉辦之「櫃買市場業績發表會」","clause":"第12款","fact_date":"2026-11-24","cite_as":"公開資訊觀測站重大訊息：太醫（4126），2026-11-20 15:00，「本公司受邀參加櫃買中心舉辦之「櫃買市場業績發表會」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-11-20-1450-1fqkmsr","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-11-20","time":"14:50:58","subject":"澄清媒體報導","clause":"第26款","fact_date":"2026-11-20","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-11-20 14:50，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6130-2026-11-20-1400-n30hzw","company_id":"6130","company":"上亞科技","market":"上櫃","industry":"生技醫療","date":"2026-11-20","time":"14:00:07","subject":"公告本公司召開法人說明會","clause":"第12款","fact_date":"2026-11-24","cite_as":"公開資訊觀測站重大訊息：上亞科技（6130），2026-11-20 14:00，「公告本公司召開法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4726-2026-11-20-1146-s0kpz3","company_id":"4726","company":"永昕","market":"上櫃","industry":"生技醫療","date":"2026-11-20","time":"11:46:37","subject":"公告本公司董事會推選董事長","clause":"第6款","fact_date":"2026-11-20","cite_as":"公開資訊觀測站重大訊息：永昕（4726），2026-11-20 11:46，「公告本公司董事會推選董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-11-20-1042-176tpaa","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-11-20","time":"10:42:05","subject":"本公司董事會決議召開115年股東臨時會相關事宜(因電子投票平台亂碼，故配合重新上傳)","clause":"第32款","fact_date":"2026-10-16","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-11-20 10:42，「本公司董事會決議召開115年股東臨時會相關事宜(因電子投票平台亂碼，故配合重新上傳)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}